Joseph Thome, Ph.D.

Managing Director, Health Care - Biotechnology

Joseph Thome, Vice President, Health Care - Biotechnology

Joseph Thome is a managing director and senior research analyst on Cowen and Company’s biotechnology team. Dr. Thome was selected as a “Rising Star in Equity Research” by Business Insider in 2021 and the Cowen biotechnology team has consistently been among the top-ranked teams in the Greenwich Survey.

Prior to joining Cowen in March 2016, Dr. Thome was an NIH pre-doctoral research fellow at Columbia University, studying the compartmentalization and maintenance of the human T cell immune response from infancy into adulthood. His research has been published in several prestigious journals including Cell and Nature Medicine.

Dr. Thome received a BA with high honors in chemistry and biochemistry from Oberlin College and a Ph.D. in microbiology and immunology from Columbia University, where he was granted the Dean’s Award for Excellence in Research. HCBiopharma

Get In Touch

Start a conversation with Joseph Thome

    Insights

    Explore related thought leadership, reports, coverage and insights for Joseph Thome.

    Petri dish of pills under FDA review. Representative of navigating FDA regulation post Covid.
    Ahead of the Curve®

    Trials & Triumphs of the FDA: What Matters? Where are We?

    Read More >
    Video

    ESG Best Ideas 2022

    Read More >
    Ahead of the Curve®

    Trials and Triumphs of Gene Editing: A Compendium

    Read More >

    Research Contacts

    Our Research team is led by seasoned, entrepreneurial-minded individuals who are driven by a relentless curiosity to redefine expectations.

    Meet Our People
    Senior businessman handshaking with young woman in the office